Literature DB >> 28614081

Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis.

Marta Gravito-Soares1, Elisa Gravito-Soares, Sandra Lopes, Graça Ribeiro, Pedro Figueiredo.   

Abstract

INTRODUCTION AND AIM: Spontaneous bacterial peritonitis is the most common infectious complication in cirrhosis. Spontaneous fungal peritonitis is rare and remains unknown. In this work, spontaneous fungal peritonitis as well as risk factors and prognosis are characterized. PATIENTS AND METHODS: A retrospective case-control study of 253 consecutive admissions by peritonitis in cirrhotic patients was carried out between 2006 and 2015. Comparison of patients with spontaneous fungal peritonitis (cases) and spontaneous bacterial peritonitis with positive microbiologic ascitic fluid culture (controls) was performed. Variables such as sociodemographic and clinical features, cirrhosis etiology, liver dysfunction scores, ascitic and laboratory parameters, invasive procedures, and prognosis were evaluated.
RESULTS: Of the 231 patients, eight (3.5%) developed spontaneous fungal peritonitis, 62.5% of cases being coinfected with bacteria. Candida spp. was isolated in 87.5% of cases, mainly Candida albicans (37.5%) and C. krusei (25.0%). Patients with spontaneous fungal peritonitis had higher ascitic fluid lactate dehydrogenase (288.4±266.6 vs. 161.0±179.5; P=0.011), blood leukocyte count (15187.5±5432.3 vs. 10969.8±6949.5; P=0.028), blood urea nitrogen (69.8±3.1 vs. 36.3±25.5; P=0.001), higher number of invasive procedures (colonoscopy: 25.0 vs. 0.8%, P=0.001; urinary catheterization: 87.5 vs. 49.6%, P=0.038; nasogastric intubation: 87.5 vs. 26.9%, P=0.001), and longer duration of hospital stay (30.0±32.9 vs. 18.9±17.0 days; P=0.031). No statistical difference was found between the two groups for Model for End-Stage Liver Disease, Model for End-Stage Liver Disease-sodium, and Child-Pugh scores. Spontaneous fungal peritonitis was associated with a worse prognosis, particularly severe sepsis/septic shock (87.5 vs. 42.8%, P=0.023), admission in the gastroenterology intensive care unit (87.5 vs. 24.4%; P=0.001), and overall (62.5 vs. 31.9%; P=0.039) or 30-day mortality (50.0 vs. 24.4%; P=0.034), with a mean diagnosis-death time of 17.6±11.5 days.
CONCLUSION: Despite being a rare condition, spontaneous fungal peritonitis was associated with worse prognosis and higher mortality than SBP. The ascitic fluid lactate dehydrogenase, blood leukocyte count and urea nitrogen, invasive procedures, and longer admission time were independent risk factors for spontaneous fungal peritonitis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28614081     DOI: 10.1097/MEG.0000000000000927

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

Review 1.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

2.  Cryptic but Deadly: A Serious Killer in Patients with Advanced Liver Disease that Should Not Be Missed.

Authors:  Jeffrey Berinstein; Alisa Likhitsup; Sai Charan Vedula; Hari Conjeevaram
Journal:  Cureus       Date:  2017-12-21

Review 3.  Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.

Authors:  Toru Shizuma
Journal:  World J Hepatol       Date:  2018-02-27

Review 4.  Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.

Authors:  Siang Fei Yeoh; Tae Jin Lee; Ka Lip Chew; Stephen Lin; Dennis Yeo; Sajita Setia
Journal:  Infect Drug Resist       Date:  2018-05-30       Impact factor: 4.003

5.  Spontaneous fungal peritonitis: Micro-organisms, management and mortality in liver cirrhosis-A systematic review.

Authors:  Tooba Tariq; Furqan B Irfan; Mehdi Farishta; Brian Dykstra; Eric Martin Sieloff; Archita P Desai
Journal:  World J Hepatol       Date:  2019-07-27

6.  Guidelines on the management of ascites in cirrhosis.

Authors:  Guruprasad P Aithal; Naaventhan Palaniyappan; Louise China; Suvi Härmälä; Lucia Macken; Jennifer M Ryan; Emilie A Wilkes; Kevin Moore; Joanna A Leithead; Peter C Hayes; Alastair J O'Brien; Sumita Verma
Journal:  Gut       Date:  2020-10-16       Impact factor: 23.059

7.  Identifying early indicators of secondary peritonitis in critically ill patients with cirrhosis.

Authors:  Carole Ruault; Nathalie Zappella; Julien Labreuche; Pierrick Cronier; Baptiste Claude; Marc Garnier; Antoine Vieillard-Baron; Sofia Ortuno; Maxime Mallet; Olga Cosic; Laura Crosby; Olivier Lesieur; Nicolas Pichon; Arnaud Galbois; Cedric Bruel; Kenneth Ekpe; Bertrand Sauneuf; Damien Roux; Stephane Legriel
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

Review 8.  Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.

Authors:  Elda Righi
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.